RecruitingPhase 3NCT07516769

Nicorandil as Anti-inflammatory in Rheumatoid Arthritis

Clinical Study Evaluating the Effect of Nicorandil as Anti-inflammatory and Immune Modulatory in Patients With Rheumatoid Arthritis

Sponsor

Tanta University

Enrollment

46 participants

Start Date

Nov 1, 2024

Study Type

INTERVENTIONAL

Conditions

Rhumatoid Arthisis

Summary

This study aims to evaluate the possible efficacy and safety of nicorandil as anti-inflammatory in managing patients with active rheumatoid arthritis.

Eligibility

Min Age: 18 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Nicorandil 10 MG Oral Tablet for people with rhumatoid arthisis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 70 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.